Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity

Authors

Shan Wang, Vanderbilt University
Ariel Raybuck, Vanderbilt University
Eileen Shiuan, Vanderbilt University
Sung Hoon Cho, Vanderbilt University
Qingfei Wang, University of Notre Dame
Dana M Brantley-Sieders, Vanderbilt University
Deanna Edwards, Vanderbilt University
Margaret M Allaman, Vanderbilt University
James Nathan, University of Cambridge
Keith T Wilson, Vanderbilt University
David DeNardo, Washington University School of Medicine in St. Louis
Siyuan Zhang, University of Notre Dame
Rebecca Cook, Vanderbilt University
Mark Boothby, Vanderbilt University
Jin Chen, Vanderbilt University

Journal

JCI Insight

Publication Date

8-6-2020

Volume

5

Issue

15

First Page

139237

Document Type

Open Access Publication

DOI

10.1172/jci.insight.139237

Rights and Permissions

Wang S, Raybuck A, Shiuan E, et al. Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity. JCI Insight. 2020;5(15):139237. Published 2020 Aug 6. doi:10.1172/jci.insight.139237 © 2020 Wang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Wang, Shan; Raybuck, Ariel; Shiuan, Eileen; Cho, Sung Hoon; Wang, Qingfei; Brantley-Sieders, Dana M; Edwards, Deanna; Allaman, Margaret M; Nathan, James; Wilson, Keith T; DeNardo, David; Zhang, Siyuan; Cook, Rebecca; Boothby, Mark; and Chen, Jin, "Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity." JCI Insight. 5, 15. 139237 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9326